Alkermes To Spin Out Oncology Business, Says Inflation Reduction Act Boosts Its Value

Company Raised CNS Product Revenue Guidance

 
• By Mandy Jackson
  
chain with arrows splits into two
The oncology business will split off from Alkermes in H2 2023 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business